Model for End-Stage Liver Disease and Sodium Velocity Predicts Overall Survival in Nonmetastatic Hepatocellular Carcinoma Patients

Table 3

Initial treatment modality grouped by MELD-Na increases cutoff of 40%. One patient had missing information regarding initial treatment modality. TACE = transcatheter arterial chemoembolization, RFA = radiofrequency ablation, Y-90 = yttrium-90 radioembolization, and SBRT = stereotactic body radiation therapy. Total percent may not add up to 100% due to rounding.

Initial Treatment Modality Within 60 Days of Diagnosis	MELD-Na Increase from Baseline
	<40, n=131	≥40, n=51
TACE, n ()	61 (47)	18 (35)
RFA, n ()	18 (14)	5 (10)
Sorafenib, n ()	14 (11)	9 (18)
Resection, n ()	13 (10)	1 (2)
Y-90, n ()	10 (8)	2 (4)
SBRT, n ()	0 (0)	1 (2)
Transplant, n ()	1 (1)	0 (0)
None, n ()	13 (10)	15 (29)